{"transactions":[{"id":1281931,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T23:32:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":124714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":124714,"derivative":{"exercise_price":1.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":124714},"source":{"system":"sec-edgar","filing":"0001725160-25-000041","document":"wk-form4_1738798344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000041/wk-form4_1738798344.xml","form_type":"4"}},{"id":1281930,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-05T23:32:31.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":14368,"price":1.7115,"value":24590.832,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."}],"balance_after":512856,"source":{"system":"sec-edgar","filing":"0001725160-25-000041","document":"wk-form4_1738798344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000041/wk-form4_1738798344.xml","form_type":"4"}},{"id":1281929,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-05T23:32:31.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":335907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":527224,"source":{"system":"sec-edgar","filing":"0001725160-25-000041","document":"wk-form4_1738798344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000041/wk-form4_1738798344.xml","form_type":"4"}},{"id":1314907,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:17:05.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":4411,"price":3.12,"value":13762.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."}],"balance_after":191317,"source":{"system":"sec-edgar","filing":"0001725160-25-000002","document":"wk-form4_1735942617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000002/wk-form4_1735942617.xml","form_type":"4"}},{"id":1658983,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:15:34.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. The options are Reporting Person's annual equity grants, which reflect the market data for Reporting Person's role as Chief Scientific Officer, a role to which he was promoted on December 31, 2023."}],"balance_after":141000,"derivative":{"exercise_price":11.69,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0001725160-24-000034","document":"wk-form4_1707178516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000034/wk-form4_1707178516.xml","form_type":"4"}},{"id":1658982,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-06T00:15:34.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":1585,"price":11.54,"value":18290.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.35 to $11.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":195728,"source":{"system":"sec-edgar","filing":"0001725160-24-000034","document":"wk-form4_1707178516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000034/wk-form4_1707178516.xml","form_type":"4"}},{"id":1658981,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-06T00:15:34.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":197313,"source":{"system":"sec-edgar","filing":"0001725160-24-000034","document":"wk-form4_1707178516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000034/wk-form4_1707178516.xml","form_type":"4"}},{"id":1692676,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T01:21:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted to the Reporting Person in connection with Reporting Person's previously disclosed promotion to Chief Scientific Officer, which became effective December 31, 2023. The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":60000,"derivative":{"exercise_price":15.99,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001725160-24-000004","document":"wk-form4_1704331256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000004/wk-form4_1704331256.xml","form_type":"4"}},{"id":1692675,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-04T01:21:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person in connection with Reporting Person's previously disclosed promotion to Chief Scientific Officer, which became effective December 31, 2023. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the vesting commencement date of December 31, 2023, subject to the Reporting Person's continuing service with the Issuer."}],"balance_after":56313,"source":{"system":"sec-edgar","filing":"0001725160-24-000004","document":"wk-form4_1704331256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000004/wk-form4_1704331256.xml","form_type":"4"}},{"id":2828914,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-27T00:10:16.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2021 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":45000,"derivative":{"exercise_price":19.52,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001567619-21-005114","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921005114/doc1.xml","form_type":"4"}},{"id":2868426,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":33014,"derivative":{"exercise_price":6.98,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":596},"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868425,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":1104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":33610,"derivative":{"exercise_price":6.98,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":1104},"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868424,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":34714,"derivative":{"exercise_price":6.98,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868423,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":596,"price":21,"value":12516.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868422,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":596,"price":6.98,"value":4160.08,"ownership":{"direct":true},"balance_after":596,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868421,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":1104,"price":21.0456,"value":23234.3424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.00 to $21.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868420,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":1104,"price":6.98,"value":7705.92,"ownership":{"direct":true},"balance_after":1104,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868419,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":200,"price":21,"value":4200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868418,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":100,"price":21.02,"value":2102.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2868417,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-02-10T23:53:12.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":300,"price":6.98,"value":2094.0,"ownership":{"direct":true},"balance_after":300,"source":{"system":"sec-edgar","filing":"0001567619-21-002852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921002852/doc1.xml","form_type":"4"}},{"id":2891836,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"exercise","acquired":false,"shares":1123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":35014,"derivative":{"exercise_price":6.98,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":1123},"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":2891835,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"exercise","acquired":false,"shares":377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vest on the first anniversary measured from May 31, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":61760,"derivative":{"exercise_price":4.62,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":377},"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":2891834,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":800,"price":18.7919,"value":15033.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $18.68 to $18.895, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":2891833,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":1701,"price":18.2977,"value":31124.3877,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $17.68 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":2891832,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"exercise","acquired":true,"shares":1123,"price":6.98,"value":7838.54,"ownership":{"direct":true},"balance_after":2501,"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":2891831,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2021-01-28T21:59:26.000Z","date":"2021-01-26","kind":"exercise","acquired":true,"shares":377,"price":4.62,"value":1741.74,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,001 shares acquired pursuant to Issuer's Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":1378,"source":{"system":"sec-edgar","filing":"0001567619-21-001669","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921001669/doc1.xml","form_type":"4"}},{"id":3105028,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-17","kind":"exercise","acquired":false,"shares":373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from May 31, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":62137,"derivative":{"exercise_price":4.62,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":373},"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105027,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-16","kind":"exercise","acquired":false,"shares":2863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on the first anniversary measured from December 11, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":36137,"derivative":{"exercise_price":6.98,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":2863},"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105026,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-16","kind":"exercise","acquired":false,"shares":3887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from May 31, 2018 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":62510,"derivative":{"exercise_price":4.62,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":3887},"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105025,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":373,"price":19.9135,"value":7427.7355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $19.84 to $19.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105024,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-17","kind":"exercise","acquired":true,"shares":373,"price":4.62,"value":1723.26,"ownership":{"direct":true},"balance_after":373,"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105023,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":6750,"price":14.9275,"value":100760.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $14.84 to $15.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105022,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-16","kind":"exercise","acquired":true,"shares":2863,"price":6.98,"value":19983.74,"ownership":{"direct":true},"balance_after":6750,"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3105021,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-18T22:03:29.000Z","date":"2020-06-16","kind":"exercise","acquired":true,"shares":3887,"price":4.62,"value":17957.94,"ownership":{"direct":true},"balance_after":3887,"source":{"system":"sec-edgar","filing":"0001567619-20-012387","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012387/doc1.xml","form_type":"4"}},{"id":3121587,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-04T21:40:15.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":104,"price":10.1054,"value":1050.9616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades in prices ranging from $10.09 to $10.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 845 shares acquired pursuant to Issuer's Employee Stock Purchase Plan on May 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-011730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920011730/doc1.xml","form_type":"4"}},{"id":3121586,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-04T21:40:15.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":333,"price":9.7321,"value":3240.7893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $9.09 to $10.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 845 shares acquired pursuant to Issuer's Employee Stock Purchase Plan on May 29, 2020."}],"balance_after":104,"source":{"system":"sec-edgar","filing":"0001567619-20-011730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920011730/doc1.xml","form_type":"4"}},{"id":3121585,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Common Stock","published_at":"2020-06-04T21:40:15.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":408,"price":8.5475,"value":3487.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $8.05 to $9.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 845 shares acquired pursuant to Issuer's Employee Stock Purchase Plan on May 29, 2020."}],"balance_after":437,"source":{"system":"sec-edgar","filing":"0001567619-20-011730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920011730/doc1.xml","form_type":"4"}},{"id":3248375,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":83558,"kind":"person","name":"Lackner Mark","position":1,"cik":"0001777413","reported_name":"Lackner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Biology"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-25T21:03:28.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2020 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":6.92,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-20-004803","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920004803/doc1.xml","form_type":"4"}}]}